Danish researchers are waiting for the rapid approval of trials with klorokin, despite the Swedish medical bad experiences.
Several Swedish hospitals have discontinued the use of malariamidlet klorokin for the treatment of coronasyge patients.
It applies, for example, Södersygehuset in Stockholm and the Sahlgrenska university hospital in Gothenburg, writes the media, Expressen and Göteborg-Posten, according to Jyllands-Posten.
this tells doctors about the serious side effects of the use of the disputed means.
In Denmark, is a trial with klorokin right on the stairs.
500 patients with Covid-19 the country over, to test whether malariamidlet mitigates the course of the disease.
It modifies the reports on the Swedish experience is not, says professor Thomas Benfield, Hvidovre Hospital, which is leading the project.
– The here experience, which is described from the Swedish hospitals, shows just how important it is to examine the effect of the drug. And, not least, about the effect of the drug outweigh the side effects that may be.
– You can’t reason himself forward to such a thing. You have to go the hard way and examine it, and it is what we do, he says.
According to the professor is an authorisation to the Danish trials imminent.
– We have searched the authorities and the ethical committee for permission to undertake the experiment. We expect an approval or a conditional approval very soon, maybe already on Tuesday. And then we can go in the time after easter, he says.
the Midlet must be used for severely ill patients who are hospitalized in the country’s hospitals.
Half of the patients will be treated with the remedy. The other half will be treated with an ineffective drug, called a placebo.
It is entirely voluntary whether you want to be with in the experiment, stresses Thomas Benfield.
It is not all Swedish hospitals that have set the treatment with the agent.
for Example, continues to use it at the Karolinska university Hospital.
In France, the authorities have given permission for the agent can be used in the treatment of seriously ill coronapatienter.
Thomas Benfield waiting to be ready with the first results from the Danish experiments for the autumn.
the Experiment with klorokin is one of several Danish projects that are underway or on the way.
Researchers are testing, for example, the preparation Remdesivir, originally developed to fight viruses like ebola and sars.
the Trial is set in motion at copenhagen university hospital.
in Addition, researchers from Aarhus university Hospital in the weekend initiated a trial of a japanese drug against heartburn – camostat mesylate.
the 180 patients included in the trial, which will clarify whether the use of the remedy can provide coronapatienter a milder course of treatment.
/ritzau/
